Bio-Rad Laboratories (BIO-B) Raw Materials (2009 - 2022)

Bio-Rad Laboratories (BIO-B) has 14 years of Raw Materials data on file, last reported at $188.5 million in Q2 2022.

• Raw Materials for Q2 2022 came in at $188.5 million, up 56.87% year-over-year; the trailing twelve-month figure through Jun 2022 was $188.5 million (up 56.87% YoY), and the FY2021 annual result was $116.9 million, down 7.9% from the prior year.
• Raw Materials rose to $188.5 million in Q2 2022 per BIO-B's latest filing, from $146.2 million in the prior quarter.
• Over five years, Raw Materials peaked at $188.5 million in Q2 2022 and troughed at $104.0 million in Q1 2020.
• A 5-year average of $123.3 million and a median of $118.3 million in 2018 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2021 and 2022: Raw Materials dropped 18.41% in 2021, then soared 56.87% in 2022.
• A 5-year view of Raw Materials shows it stood at $108.0 million in 2018, then gained by 1.45% to $109.6 million in 2019, then gained by 15.83% to $126.9 million in 2020, then dropped by 7.9% to $116.9 million in 2021, then jumped by 61.26% to $188.5 million in 2022.
• Business Quant data shows BIO-B's Raw Materials at $188.5 million in Q2 2022, $146.2 million in Q1 2022, and $116.9 million in Q4 2021.